9 Item 1A. Risk Factors 37 Item 1B. Unresolved SEC Comments 64 Item 1C. Cybersecurity 64 Item 2. Properties 65 Item 3. Legal Proceedings 65 Item 4. Mine Safety Disclosures 66 PART II. Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 67 Item 6. Reserved 67 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 67 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 76 Item 8. Fi...
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076551 | EDGAR | 79K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-029002 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0000950170-24-021096 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0001140361-23-009252 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001140361-22-007036 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001140361-21-006677 | EDGAR | — |
| 2020-03-06 | 2019-12-31 | 0001140361-20-005056 | EDGAR | — |
| 2019-03-08 | 2018-12-31 | 0001140361-19-004603 | EDGAR | — |
| 2018-03-07 | 2017-12-31 | 0001564590-18-004621 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004532 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269474 | EDGAR | 29K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104996 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066898 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123459 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091838 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0000950170-24-054465 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060339 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001140361-23-038855 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0001140361-23-023233 | EDGAR | — |
| 2022-11-04 | 2022-09-30 | 0001140361-22-040004 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001140361-22-028904 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0001140361-22-018101 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001140361-26-011573 | EDGAR | 2K words |
| 2026-03-10 | 0001140361-26-008853 | EDGAR | — |
| 2026-02-26 | 0001140361-26-006981 | EDGAR | — |
| 2025-11-06 | 0001140361-25-040774 | EDGAR | — |
| 2025-10-14 | 0001140361-25-038030 | EDGAR | — |
| 2025-10-03 | 0001140361-25-037237 | EDGAR | — |
| 2025-10-03 | 0001140361-25-037163 | EDGAR | — |
| 2025-09-29 | 0001140361-25-036556 | EDGAR | — |
| 2025-09-17 | 0001140361-25-035251 | EDGAR | — |
| 2025-08-25 | 0001140361-25-032502 | EDGAR | — |
234 total filings indexed. 202 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001281895 |
| Ticker | RCKT |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.rocketpharma.com |
| Listed | 2015-02-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report